613 related articles for article (PubMed ID: 26386501)
21. Sacubitril/Valsartan (LCZ696) in Heart Failure.
Khder Y; Shi V; McMurray JJV; Lefkowitz MP
Handb Exp Pharmacol; 2017; 243():133-165. PubMed ID: 28004291
[TBL] [Abstract][Full Text] [Related]
22. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
Jhund PS; Claggett BL; Voors AA; Zile MR; Packer M; Pieske BM; Kraigher-Krainer E; Shah AM; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
Circ Heart Fail; 2014 Nov; 7(6):953-9. PubMed ID: 25277997
[TBL] [Abstract][Full Text] [Related]
23. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.
McMurray J; Packer M; Desai A; Gong J; Greenlaw N; Lefkowitz M; Rizkala A; Shi V; Rouleau J; Solomon S; Swedberg K; Zile MR; Andersen K; Arango JL; Arnold M; Bĕlohlávek J; Böhm M; Boytsov S; Burgess L; Cabrera W; Chen CH; Erglis A; Fu M; Gomez E; Gonzalez A; Hagege AA; Katova T; Kiatchoosakun S; Kim KS; Bayram E; Martinez F; Merkely B; Mendoza I; Mosterd A; Negrusz-Kawecka M; Peuhkurinen K; Ramires F; Refsgaard J; Senni M; Sibulo AS; Silva-Cardoso J; Squire I; Starling RC; Vinereanu D; Teerlink JR; Wong R;
Eur Heart J; 2015 Feb; 36(7):434-9. PubMed ID: 25416329
[TBL] [Abstract][Full Text] [Related]
24. Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.
Simpson J; Jhund PS; Silva Cardoso J; Martinez F; Mosterd A; Ramires F; Rizkala AR; Senni M; Squire I; Gong J; Lefkowitz MP; Shi VC; Desai AS; Rouleau JL; Swedberg K; Zile MR; McMurray JJV; Packer M; Solomon SD;
J Am Coll Cardiol; 2015 Nov; 66(19):2059-2071. PubMed ID: 26541915
[TBL] [Abstract][Full Text] [Related]
25. Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
McMurray JJ; Packer M; Desai AS; Gong J; Lefkowitz M; Rizkala AR; Rouleau JL; Shi VC; Solomon SD; Swedberg K; Zile MR;
Eur J Heart Fail; 2014 Jul; 16(7):817-25. PubMed ID: 24828035
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.
Solomon SD; Rizkala AR; Gong J; Wang W; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; Desai AS; Shi VC; Lefkowitz MP; McMurray JJV
JACC Heart Fail; 2017 Jul; 5(7):471-482. PubMed ID: 28662936
[TBL] [Abstract][Full Text] [Related]
27. Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure.
Vardeny O; Miller R; Solomon SD
JACC Heart Fail; 2014 Dec; 2(6):663-70. PubMed ID: 25306450
[TBL] [Abstract][Full Text] [Related]
28. Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan.
Liu RC
Am J Cardiovasc Drugs; 2018 Dec; 18(6):473-482. PubMed ID: 29850980
[TBL] [Abstract][Full Text] [Related]
29. Neprilysin Inhibition as a PARADIGM Shift in Heart Failure Therapy.
Hsiao R; Greenberg B
Curr Heart Fail Rep; 2016 Aug; 13(4):172-80. PubMed ID: 27271564
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-Neprilysin Inhibition as a Paradigm for All?
Vaduganathan M; Desai AS
Curr Cardiol Rep; 2016 Nov; 18(11):115. PubMed ID: 27747488
[TBL] [Abstract][Full Text] [Related]
31. Prospective Comparison of ARNi with ACE-I to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF): paragon of a study or further investigation paramount?
Krum H
Circulation; 2015 Jan; 131(1):11-2. PubMed ID: 25411157
[No Abstract] [Full Text] [Related]
32. Role of Neprilysin Inhibitors in Heart Failure.
Salazar Adum JP; Arora R
Am J Ther; 2017; 24(6):e737-e743. PubMed ID: 26580582
[TBL] [Abstract][Full Text] [Related]
33. Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM.
Lillyblad MP
Ann Pharmacother; 2015 Nov; 49(11):1237-51. PubMed ID: 26175499
[TBL] [Abstract][Full Text] [Related]
34. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
Cannon JA; Shen L; Jhund PS; Kristensen SL; Køber L; Chen F; Gong J; Lefkowitz MP; Rouleau JL; Shi VC; Swedberg K; Zile MR; Solomon SD; Packer M; McMurray JJ;
Eur J Heart Fail; 2017 Jan; 19(1):129-137. PubMed ID: 27868321
[TBL] [Abstract][Full Text] [Related]
35. [The new drug is much more effective than ACE inhibitors in chronic heart failure].
Widimský J
Vnitr Lek; 2015 Feb; 61(2):129-33. PubMed ID: 25813256
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
Balmforth C; Simpson J; Shen L; Jhund PS; Lefkowitz M; Rizkala AR; Rouleau JL; Shi V; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
JACC Heart Fail; 2019 Jun; 7(6):457-465. PubMed ID: 31078482
[TBL] [Abstract][Full Text] [Related]
37. Neprilysin Inhibitors: Emerging Therapy for Heart Failure.
Owens AT; Brozena S; Jessup M
Annu Rev Med; 2017 Jan; 68():41-49. PubMed ID: 27686019
[TBL] [Abstract][Full Text] [Related]
38. PARADIGM-HF--the experts' discussion.
Jessup M; Fox KA; Komajda M; McMurray JJ; Packer M
N Engl J Med; 2014 Sep; 371(11):e15. PubMed ID: 25184757
[No Abstract] [Full Text] [Related]
39. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Jhund PS; Claggett B; Packer M; Zile MR; Voors AA; Pieske B; Lefkowitz M; Shi V; Bransford T; McMurray JJ; Solomon SD
Eur J Heart Fail; 2014 Jun; 16(6):671-7. PubMed ID: 24692284
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
